Novello, S., Torri, V., Grohé, C., Kurz, S., Serke, M., Wehler, T., . . . Scagliotti, G. V. (2022). International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer. Annals of oncology, 33(1), . https://doi.org/10.1016/j.annonc.2021.09.017
Chicago-Zitierstil (17. Ausg.)Novello, Silvia, et al. "International Tailored Chemotherapy Adjuvant (ITACA) Trial, a Phase III Multicenter Randomized Trial Comparing Adjuvant Pharmacogenomic-driven Chemotherapy Versus Standard Adjuvant Chemotherapy in Completely Resected Stage II-IIIA Non-small-cell Lung Cancer." Annals of Oncology 33, no. 1 (2022). https://doi.org/10.1016/j.annonc.2021.09.017.
MLA-Zitierstil (9. Ausg.)Novello, Silvia, et al. "International Tailored Chemotherapy Adjuvant (ITACA) Trial, a Phase III Multicenter Randomized Trial Comparing Adjuvant Pharmacogenomic-driven Chemotherapy Versus Standard Adjuvant Chemotherapy in Completely Resected Stage II-IIIA Non-small-cell Lung Cancer." Annals of Oncology, vol. 33, no. 1, 2022, https://doi.org/10.1016/j.annonc.2021.09.017.